1074 related articles for article (PubMed ID: 10556035)
21. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
22. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous humanization and affinity optimization of monoclonal antibodies.
Wu H
Methods Mol Biol; 2003; 207():197-212. PubMed ID: 12412476
[No Abstract] [Full Text] [Related]
24. Human framework adaptation of a mouse anti-human IL-13 antibody.
Fransson J; Teplyakov A; Raghunathan G; Chi E; Cordier W; Dinh T; Feng Y; Giles-Komar J; Gilliland G; Lollo B; Malia TJ; Nishioka W; Obmolova G; Zhao S; Zhao Y; Swanson RV; Almagro JC
J Mol Biol; 2010 Apr; 398(2):214-31. PubMed ID: 20226193
[TBL] [Abstract][Full Text] [Related]
25. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
[TBL] [Abstract][Full Text] [Related]
26. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1.
Holm P; Jafari R; Sundström BE
Mol Immunol; 2007 Feb; 44(6):1075-84. PubMed ID: 16989900
[TBL] [Abstract][Full Text] [Related]
27. Humanization of a chicken anti-IL-12 monoclonal antibody.
Tsurushita N; Park M; Pakabunto K; Ong K; Avdalovic A; Fu H; Jia A; Vásquez M; Kumar S
J Immunol Methods; 2004 Dec; 295(1-2):9-19. PubMed ID: 15627607
[TBL] [Abstract][Full Text] [Related]
28. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
30. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
Baek DS; Kim YS
Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
[TBL] [Abstract][Full Text] [Related]
31. Engineering fully human monoclonal antibodies from murine variable regions.
Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
[TBL] [Abstract][Full Text] [Related]
32. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.
Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y
J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812
[TBL] [Abstract][Full Text] [Related]
33. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS
J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568
[TBL] [Abstract][Full Text] [Related]
34. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
[TBL] [Abstract][Full Text] [Related]
35. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
[TBL] [Abstract][Full Text] [Related]
36. Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Yazaki PJ; Sherman MA; Shively JE; Ikle D; Williams LE; Wong JY; Colcher D; Wu AM; Raubitschek AA
Protein Eng Des Sel; 2004 May; 17(5):481-9. PubMed ID: 15316127
[TBL] [Abstract][Full Text] [Related]
37. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
[TBL] [Abstract][Full Text] [Related]
38. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
[TBL] [Abstract][Full Text] [Related]
39. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
40. Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody.
Li B; Wang H; Zhang D; Qian W; Hou S; Shi S; Zhao L; Kou G; Cao Z; Dai J; Guo Y
Biochem Biophys Res Commun; 2007 Jun; 357(4):951-6. PubMed ID: 17451647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
